Propanc Biopharma Inc (PPCB)

OTC Markets
0.27
+0.0051(+1.93%)
After Hours
0.2548
-0.0152(-5.6296%)
- Delayed Data
  • Volume:
    63,939
  • Bid/Ask
    0.00/0.00
  • Day's Range
    0.25 - 0.27

PPCB Overview

Prev. Close
0.27
Day's Range
0.25 - 0.27
Revenue
0
Open
0.265
52 wk Range
0.0013 - 0.8499
EPS
-336.35
Volume
63,939
Market Cap
1.02M
Dividend (Yield)
N/A (N/A)
Average Volume (3m)
108,169
P/E Ratio
N/A
Beta
0.63
1-Year Change
400%
Shares Outstanding
3,782,448
Next Earnings Date
29 Nov 2
What is your sentiment on Propanc Biopharma Inc?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralNeutralSellStrong Sell
Technical IndicatorsBuyStrong BuyBuyStrong SellStrong Sell
SummaryNeutralBuyNeutralStrong SellStrong Sell

Propanc Biopharma Inc Company Profile

Propanc Biopharma Inc Company Profile

Employees
1

Propanc Biopharma, Inc., formerly Propanc Health Group Corporation, is an early-stage healthcare company that is focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancer. The Company has developed a composite formulation of anti-cancer compounds, which together exert a range of effects designed to control or prevent tumors from recurring and spreading through the body. The Company's solution is to develop and commercialize a long-term therapy to prevent tumor recurrence and metastases. It is developing pro-enzyme therapy for the treatment and prevention of the development of carcinomas from solid tumors. The Company's products include PRP and PRP-DCM. The Company's PRP is a formulation consisting of two pro-enzymes: trypsinogen and chymotrypsinogen, plus the enzyme amylase (1, 4-alpha-D-glucan glucanohydrolase). The pro-enzymes in PRP, typsinogen and chymotrypsinogen, exhibit specificity for tumor cells and not normal cells.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.